About Alexander Kasper
Form D filings for Zurex Pharma from 2014 to 2023 list Alexander Kasper as chief executive officer and director.
Alexander Kasper first appears on SEC filings in 2014.
Experience
This experience comes from SEC filings. The years are when the filings name Alexander Kasper in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Alexander Kasper works with at each company, as listed on that company's latest Form D.
Zurex Pharma, Inc. · Form D, Dec 29, 2023
FR
Frederick Robertson
Director